Mereo BioPharma Group plc
MREO
$1.77
$0.0251.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.81% | 28.41% | 21.56% | 50.46% | 63.37% |
| Total Receivables | 85.50% | 45.51% | -11.08% | -- | -85.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.79% | -26.84% | -66.05% | -- | 0.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -85.27% | -59.96% | -17.41% | -- | -- |
| Total Current Assets | -34.62% | 25.05% | 17.26% | -- | 36.32% |
|
|
|||||
| Total Current Assets | -34.62% | 25.05% | 17.26% | -- | 36.32% |
| Net Property, Plant & Equipment | -44.07% | -40.84% | -40.36% | -- | -33.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -45.73% | -43.00% | -40.96% | -- | -97.26% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -34.85% | 22.14% | 14.87% | -- | -6.19% |
|
|
|||||
| Total Accounts Payable | -64.84% | 28.76% | 14.02% | -- | 44.29% |
| Total Accrued Expenses | -11.32% | 9.80% | -20.41% | -- | -1.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -89.29% | -85.88% | 857.36% | -- | -5.55% |
| Total Finance Division Other Current Liabilities | 15.87% | 13.76% | -51.82% | -- | -95.68% |
| Total Other Current Liabilities | 15.87% | 13.76% | -51.82% | -- | -95.68% |
| Total Current Liabilities | -51.14% | -31.87% | 45.98% | -- | -30.29% |
|
|
|||||
| Total Current Liabilities | -51.14% | -31.87% | 45.98% | -- | -30.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -79.36% | -- | -55.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -38.60% | -45.61% | 17.86% | -- | 44.25% |
| Total Liabilities | -51.63% | -37.09% | -3.39% | -- | -39.92% |
|
|
|||||
| Common Stock & APIC | 2.18% | 11.78% | 11.01% | -- | 63.21% |
| Retained Earnings | -10.39% | -10.14% | -10.31% | -- | -1.37% |
| Treasury Stock & Other | 52.71% | 16.37% | -0.72% | -- | -110.23% |
| Total Common Equity | -31.12% | 40.25% | 20.64% | -1.15% | 7.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -31.12% | 40.25% | 20.64% | -1.15% | 7.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -31.12% | 40.25% | 20.64% | -1.15% | 7.18% |
|
|
|||||